IGC Pharma Inc (IGC)
0.50
-0.04
(-7.75%)
USD |
NYAM |
May 01, 16:00
0.5236
+0.02
(+4.72%)
After-Hours: 19:24
IGC Pharma Cash from Operations (Quarterly): -1.587M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.587M |
| September 30, 2023 | -1.618M |
| June 30, 2023 | -1.468M |
| March 31, 2023 | -1.517M |
| December 31, 2022 | -1.648M |
| September 30, 2022 | -1.686M |
| June 30, 2022 | -2.196M |
| March 31, 2022 | -0.887M |
| December 31, 2021 | -2.422M |
| September 30, 2021 | -2.302M |
| June 30, 2021 | -1.851M |
| March 31, 2021 | -2.505M |
| December 31, 2020 | -1.845M |
| September 30, 2020 | -2.462M |
| June 30, 2020 | -3.988M |
| March 31, 2020 | -1.993M |
| December 31, 2019 | -2.24M |
| September 30, 2019 | -1.572M |
| June 30, 2019 | -2.872M |
| March 31, 2019 | -1.148M |
| December 31, 2018 | -1.331M |
| September 30, 2018 | -0.316M |
| June 30, 2018 | -0.535M |
| March 31, 2018 | -0.958M |
| December 31, 2017 | -0.346M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.1051M |
| June 30, 2017 | -0.5219M |
| March 31, 2017 | -0.908M |
| December 31, 2016 | 0.1937M |
| September 30, 2016 | -0.8796M |
| June 30, 2016 | 0.2029M |
| March 31, 2016 | -0.1617M |
| December 31, 2015 | -0.0033M |
| September 30, 2015 | 0.5558M |
| June 30, 2015 | -0.5484M |
| March 31, 2015 | -0.456M |
| December 31, 2014 | -0.1755M |
| September 30, 2014 | -1.385M |
| June 30, 2014 | -0.5674M |
| March 31, 2014 | -0.8752M |
| December 31, 2013 | -0.451M |
| September 30, 2013 | -0.1723M |
| June 30, 2013 | -0.2436M |
| March 31, 2013 | -0.6948M |
| December 31, 2012 | 1.495M |
| September 30, 2012 | -0.1551M |
| June 30, 2012 | -0.0805M |
| March 31, 2012 | -3.824M |
| December 31, 2011 | -0.3848M |
| September 30, 2011 | -0.3885M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-3.988M
Minimum
Jun 2020
-0.887M
Maximum
Mar 2022
-2.035M
Average
-1.851M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| CEL-SCI Corp | -4.888M |
| AIM ImmunoTech Inc | -9.758M |
| NovaBay Pharmaceuticals Inc | -0.314M |
| Protalix BioTherapeutics Inc | 3.595M |
| Palatin Technologies Inc | -10.48M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.061M |
| Cash from Financing (Quarterly) | -0.001M |
| Free Cash Flow | -6.55M |
| Free Cash Flow Per Share (Quarterly) | -0.0263 |
| Free Cash Flow to Equity (Quarterly) | -1.673M |
| Free Cash Flow to Firm (Quarterly) | -1.674M |
| Free Cash Flow Yield | -23.38% |